“Clinical Response and Safety of Alternating Daily Dosage of Crizotinib Due to Side Effects in Advanced NSCLC Patient Harboring ROS1-Rearrangement: A Case Report”. Jurnal Respirologi Indonesia 43, no. 2 (April 16, 2023): 111–115. Accessed August 14, 2025. http://jurnalrespirologi.org/index.php/jri/article/view/201.